Close button
Logo
Discount sale U.S. Central Venous Catheter Market Size And Forecast To 2026

Central Venous Catheter Market – Increasing Prevalence of Cancer

Central venous catheters play a major role in modern healthcare. These catheters allow easy administration of intravenous fluids, blood products, medications, and parenteral nutrition, as well as offer hemodialysis access and hemodynamic monitoring. They are used in various diseases for longer duration therapies such as cancer (chemotherapy) and end stage renal disease (dialysis).

The U.S. central venous catheter market size was valued at US$ 825.9 million in 2018, and is expected to exhibit a CAGR of 6.2% over the forecast period (2018 – 2026).

Figure 1. U.S. Central Venous Catheter Market Value (US$ Mn), by Design, 2018

U.S. Central Venous Catheter  | Coherent Market Insights

                                                                     Source: Coherent Market Insights Analysis (2019)

Increasing prevalence of cancer is expected to propel growth of the central venous catheter market

Cancer is a class of chronic disease that is characterized by out-of-controlled growth of cells. According to The National Cancer Institute, 2013, there are over 100 different types of cancer that can be described from the type of cells they are formed from. According to the American Cancer Society, 2017, cancer is the second most common cause of death in the U.S., which accounts for nearly 1 out of every 4 deaths.

According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney.

According to the World Health Organization (WHO), 2012, cancer is the second leading cause of morbidity and mortality worldwide, with around 14 million new cases registered in 2012. Furthermore, WHO stated that the number of new cases is expected to increase by around 70% by 2030. In 2015, cancer was responsible for 8.8 million deaths worldwide.

Figure 2. U.S. Central Venous Catheter Market Share (%), by Design, 2018 and 2026

U.S. Central Venous Catheter  | Coherent Market Insights

                                                                    Source: Coherent Market Insights Analysis (2018)

Increasing collaboration strategies adopted by market players is expected to bolster growth of the U.S. central venous catheter market

The U.S. central venous catheter market is expected to witness significant growth due to increasing adoption of collaboration strategies by market players. For instance, in 2017, Becton, Dickinson, and Company acquired C.R. Bard, Inc. which created a new health care industry leader with approximately US$ 16 billion in annualized revenue. Similarly, in July 2018, B.Braun Melsungen AG acquired the bloodlines business of NxStage Medical, Inc. This acquisition helped dialysis business of B. Braun Melsungen AG.

Key Players

Major players operating in the U.S. central venous catheter market include, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation.

FAQ

Frequently Asked Questions

The U.S. central venous catheter market is estimated to surpass US$ 1,332.2 Million by 2026.
Major players operating in the U.S. central venous catheter market include AngioDynamics, Inc., C. R. Bard, Inc., Teleflex Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and Theragenics Corporation.
Increasing prevalence of diseasesthat require long-term therapies such as cancer (chemotherapy) and end stage renal disease (dialysis) is one of the major factors influencing adoption of central venous catheter in the U.S.
Increasing prevalence of canceris one of the major factors that is expected to propel growth of the market over the forecast period.
The U.S. central venous catheter market is estimated to exhibit a CAGR of 6.2% over the forecast period.
Among product type, peripherally inserted central catheters (PICC) segment held a dominant position in the U.S. central venous catheter market in 2018.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner

Subscribe Newsletter

Kindly subscribe for our latest news & articles.